These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33063262)

  • 1. ASO Author Reflections: Prognostic Factors in Surgically Treated Peritoneal Metastases from Colorectal Cancer.
    Baratti D; Deraco M
    Ann Surg Oncol; 2021 Jun; 28(6):3343-3344. PubMed ID: 33063262
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Cytoreductive Surgery for Colorectal Peritoneal Metastases-Is It Time to Audit Our Results?
    García-Fadrique A
    Ann Surg Oncol; 2022 Jan; 29(1):203-204. PubMed ID: 34435299
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Preoperative Serological Biomarkers as Novel Prognostic Factors in Patients with Peritoneal Metastases of Colorectal Cancer Origin.
    El Asmar A; Liberale G
    Ann Surg Oncol; 2023 Mar; 30(3):1870-1871. PubMed ID: 36336734
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Synchronous Liver and Peritoneal Metastasis From Colorectal Cancer.
    Mor E; Adileh M; Ariche A; Nissan A
    Ann Surg Oncol; 2021 Jun; 28(6):3330-3331. PubMed ID: 33005991
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Treatment and Prognosis of Colorectal Peritoneal Metastases.
    Bakkers C; Lurvink RJ; van Erning FN; Nienhuijs SW; de Hingh IHJT
    Ann Surg Oncol; 2021 Dec; 28(13):9084-9085. PubMed ID: 34091776
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: PIPAC for Unresectable Colorectal Peritoneal Metastases.
    Rovers KP; Lurvink RJ; Nienhuijs SW; de Hingh IHJT
    Ann Surg Oncol; 2021 Sep; 28(9):5327-5329. PubMed ID: 33469796
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Toward the Prediction of Peritoneal Recurrence After Curative Resection for Colon Cancer.
    Pedrazzani C; Turri G; Choi GS
    Ann Surg Oncol; 2022 Nov; 29(12):7907-7908. PubMed ID: 35829799
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: R0 Resection and Targeted Therapy for Colorectal Peritoneal Metastasis.
    Shida D
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):842-843. PubMed ID: 30324473
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: Potential Therapeutic Implications and Prediction of Pathological Complete Response to Systemic Chemotherapy in Colorectal Peritoneal Metastases.
    Bhatt A; Képénékian V; Benzerdjeb N; Glehen O
    Ann Surg Oncol; 2021 Jul; 28(7):3850-3851. PubMed ID: 33211229
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Defining the Role of PIPAC in the Treatment of Peritoneal Metastases.
    Raoof M; Dellinger T
    Ann Surg Oncol; 2022 Jan; 29(1):186-187. PubMed ID: 34312799
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: Toward Improved Selection of Patients for Cytoreduction and HIPEC: Identification of Prognostic Factors for Patients with Colorectal Peritoneal Metastases.
    Sluiter NR; Tuynman JB
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):840-841. PubMed ID: 30302638
    [No Abstract]   [Full Text] [Related]  

  • 12. ASO Author Reflections: Clinical Significance of Primary Tumor Side in Peritoneal Metastatic Colon Cancer.
    Kotha NV; Kelly KJ
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):764-765. PubMed ID: 31602580
    [No Abstract]   [Full Text] [Related]  

  • 13. ASO Author Reflections: Long-Term Outcomes After R0 Resection of Colorectal Peritoneal Metastasis.
    Shida D
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):832-833. PubMed ID: 30251024
    [No Abstract]   [Full Text] [Related]  

  • 14. ASO Author Reflections: Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal Metastases.
    Baumgartner JM; Riviere P; Kurzrock R
    Ann Surg Oncol; 2020 Sep; 27(9):3268-3269. PubMed ID: 32303875
    [No Abstract]   [Full Text] [Related]  

  • 15. ASO Author Reflections: Gastric Cancer with Peritoneal Metastasis: Are Some Patients Surgical Candidates?
    Pimiento JM; Dineen SP
    Ann Surg Oncol; 2021 Aug; 28(8):4138-4139. PubMed ID: 33866470
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic Significance of Peritoneal Metastasis in Stage IV Colorectal Cancer Patients With R0 Resection: A Multicenter, Retrospective Study.
    Arakawa K; Kawai K; Ishihara S; Hata K; Nozawa H; Oba K; Sugihara K; Watanabe T
    Dis Colon Rectum; 2017 Oct; 60(10):1041-1049. PubMed ID: 28891847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASO Author Reflections: Patterns of Metastases in Patients with Obstructing Colorectal Cancer.
    Boeding JRE; Schreinemakers JMJ
    Ann Surg Oncol; 2020 Apr; 27(4):1056-1057. PubMed ID: 32048091
    [No Abstract]   [Full Text] [Related]  

  • 18. ASO Author Reflections: What is the Best Therapeutic Strategy for Patients with Limited Synchronous Peritoneal Metastases of Colorectal Cancer?
    Mariani A; Goere D
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):818. PubMed ID: 31667730
    [No Abstract]   [Full Text] [Related]  

  • 19. ASO Author Reflections: Peritoneal Metastases from Endometrial Cancer.
    Sammartino P; Cornali T
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):882-883. PubMed ID: 30288653
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.